STAT+: Novo Nordisk’s obesity drug Wegovy cleared to treat MASH
Written by
STAT News
Published
0
comments
0
min
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.